These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 15127263)

  • 1. Successful management of a patient with neuroleptic malignant syndrome associated with marked elevation of serum creatine kinase.
    Takizawa D; Nishikawa K; Hiraoka H; Hinohara H; Saito S; Goto F; Kunimoto F
    J Anesth; 2004; 18(2):135-7. PubMed ID: 15127263
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuroleptic malignant-like syndrome induced by metoclopramide.
    Samie MR
    Mov Disord; 1987; 2(1):57-60. PubMed ID: 3504260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Malignant neuroleptic syndrome--a possibility for early diagnosis].
    Rasmussen KT; Scherling A
    Ugeskr Laeger; 1991 Oct; 153(43):3018-9. PubMed ID: 1801391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Increase in serum creatine phosphokinase following administration of talipexole hydrochloride].
    Osumi E; Imai T
    Rinsho Shinkeigaku; 2000 Oct; 40(10):1041-3. PubMed ID: 11296371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Creatine phosphokinase in a hospitalized psychiatric population].
    Manero Marcén E; Malo Ocejo P; Uriarte Uriarte JJ; Pinilla Tubet E
    Arch Neurobiol (Madr); 1992; 55(5):235-40. PubMed ID: 1362345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroleptic malignant syndrome with slight elevation of creatine kinase in serum: a brief review.
    León-Caballero J; Alba-Pale L; Salgado-Serrano P; Pérez-Solà V
    Actas Esp Psiquiatr; 2015 Sep; 43(5):194-6. PubMed ID: 26320898
    [No Abstract]   [Full Text] [Related]  

  • 7. Neuroleptic malignant syndrome with normal creatine kinase.
    Singh R; Hassanally D
    Postgrad Med J; 1996 Mar; 72(845):187. PubMed ID: 8731718
    [No Abstract]   [Full Text] [Related]  

  • 8. [Neuroleptic malignant syndrome in a patient with polyneuropathy: mechanism of muscle rigidity and elevated serum creatine kinase levels].
    Takashima S; Hirade S; Taguchi Y; Inoue H
    Rinsho Shinkeigaku; 1998; 38(10-11):955-7. PubMed ID: 10203983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Olanzapine elevation of serum creatine kinase.
    Martí-Bonmatí E; San Valero-Carcelén E; Ortega-García MP; Rubini-Puig R
    J Clin Psychiatry; 2003 Apr; 64(4):483-4. PubMed ID: 12716258
    [No Abstract]   [Full Text] [Related]  

  • 10. [Significance of serum myosin light chain-1 level in neuroleptic malignant syndrome].
    Konagaya M; Iida M; Konagaya Y
    No To Shinkei; 1994 Apr; 46(4):373-8. PubMed ID: 8024837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroleptic malignant syndrome: an underdiagnosed condition.
    Harradine PG; Williams SE; Doherty SR
    Med J Aust; 2001 Jun; 174(11):593-4. PubMed ID: 11453335
    [No Abstract]   [Full Text] [Related]  

  • 12. Does electroconvulsive therapy exacerbate the elevation of creatinine phosphokinase caused by neuroleptics.
    Geizer M; Ancill R
    Can J Psychiatry; 1996 Mar; 41(2):131. PubMed ID: 8705961
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasmapheresis in neuroleptic malignant syndrome.
    Gaitini L; Fradis M; Vaida S; Krimerman S; Beny A
    Anaesthesia; 1997 Feb; 52(2):165-8. PubMed ID: 9059103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical neuroleptic malignant syndrome in H1N1 pneumonia.
    Crosby D; Peterson J; Carroll BT
    Ann Clin Psychiatry; 2013 Feb; 25(1):69-70. PubMed ID: 23376873
    [No Abstract]   [Full Text] [Related]  

  • 15. Neuroleptic malignant syndrome in a patient with head injury.
    Perez-Vela JL; Sanchez Casado M; Sanchez-Izquierdo Riera JA; Ambros Checa A; Caballero Cubedo R; Alted Lopez E
    Intensive Care Med; 1996 Jun; 22(6):593-5. PubMed ID: 8814479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Missed neuroleptic malignant syndrome.
    Renwick DS; Chandraker A; Bannister P
    BMJ; 1992 Mar; 304(6830):831-2. PubMed ID: 1392715
    [No Abstract]   [Full Text] [Related]  

  • 17. The myth of elevated serum creatine phosphokinase level and neuroleptic malignant syndrome.
    Adityanjee
    Br J Psychiatry; 1991 May; 158():706-7. PubMed ID: 1677602
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute hypernatremia and neuroleptic malignant syndrome in Parkinson disease.
    Cao L; Katz RH
    Am J Med Sci; 1999 Jul; 318(1):67-8. PubMed ID: 10408764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How "malignant" is the neuroleptic malignant syndrome?
    Bristow MF; Kohen D
    BMJ; 1993 Nov; 307(6914):1223-4. PubMed ID: 8281048
    [No Abstract]   [Full Text] [Related]  

  • 20. [Importance of creatine kinase psychiatry--truths and myths].
    Warchala A; Kucia K; Małecki A
    Wiad Lek; 2006; 59(3-4):255-60. PubMed ID: 16813275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.